Fidia Pharma Group

Fidia Farmaceutici S.p.A. is a privately held, fully integrated Italian pharmaceutical company, with R&D, manufacturing, marketing and sales capabilities. The Company was founded in 1946 and is headquartered in Abano Terme (Italy).

Fidia operates across different therapeutic areas, focusing on commonly occurring pathologies with serious social and economic impact, age-related diseases and other health-related conditions, as life expectancy lengthens and chronic, disabling diseases increase as a result.

The company’s overall objective is establishing its leadership, through developing and marketing innovative pharmaceutical products, medical devices and healthcare ‘lifestyle’ products, primarily based on hyaluronic acid (HA) and its derivatives, thereby providing patients and healthcare professionals with a variety of treatment options.
 

Strategic areas:

- Bone and Joint Care
- Skin Care
- Mucosal Care
- Neuroscience
- Ophthalmology
- Aesthetic Medicine

Fidia
Farmaceutici S.p.A.
Website

Find out our Corporate Website:

Go to the website

Fidia’s other websites

Direct link to:

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Middle East product portfolio focalizes primarily on therapeutic areas such as joint healthcare and tissue repair.

Fidia Pharma Middle East is focused on providing consumers with innovative products that offer quality, safety and performance and exploring innovative channel strategies to access customers and consumers, such as healthcare e-commerce.